Sarcomatoid Renal Cell Carcinoma

14 clinical trials · Condition

Record	Firm	Date
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors (NCT04272034)	Incyte Corporation	2021-03-26
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study (NCT03793166)	National Cancer Institute (NCI)	2019-06-07
ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) (NCT03685448)	Australian and New Zealand Urogenital and Prostate Cancer Trials Group	2019-04-11
Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma (NCT03541902)	M.D. Anderson Cancer Center	2018-05-15
Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) (NCT03177239)	Australian and New Zealand Urogenital and Prostate Cancer Trials Group	2017-10-19
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208)	National Cancer Institute (NCI)	2015-07-22
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer (NCT01767636)	Mayo Clinic	2013-05-16
Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer (NCT00126503)	National Cancer Institute (NCI)	2005-05-01

Every clearance here is in the API, with alerts when new ones post.